Is Corcept Therapeutics Incorporated (CORT) The Most Promising Growth Stock According to Analysts?

Corcept Therapeutics Incorporated (NASDAQ:CORT) is among the most promising maturation stocks according to analysts. According to an Investing.com report, William Guyer, Chief Development Officer astatine Corcept Therapeutics Incorporated (NASDAQ:CORT), sold 20,000 shares of communal banal valued astatine $703,656 connected January 6.

Earlier connected January 2, Swayampakula Ramakanth, an expert astatine H.C. Wainwright, trimmed the terms people connected Corcept Therapeutics Incorporated (NASDAQ:CORT) to $90 from $145, portion maintaining a ‘Buy’ standing connected the stock. Slightly beneath the median terms people of $95, the revised terms people suggests an upside imaginable of astir 141%.

goodluz/Shutterstock.com

According to TheFly, this downward stance follows the FDA’s Complete Response Letter (CRL) centering connected the caller cause exertion for relacorilant arsenic a attraction for hypercortisolism successful Cushing’s syndrome. The probe steadfast reports that though the FDA acknowledged the company’s pivotal GRACE trial, which achieved the superior endpoint, and the GRADIENT proceedings provided immoderate confirmatory evidence, the regulatory bureau inactive requires further confirmatory grounds to measure the benefit-risk illustration of relacorilant. That said, the banal is presently trading astatine the lowest levels since its abrupt driblet connected December 31, 2025.

In response, Corcept Therapeutics Incorporated (NASDAQ:CORT) plans to petition a Type A gathering with the FDA to wide the way ahead. This volition springiness absorption the accidental to supply insights into their strategy by the extremity of the archetypal 4th of this year. H.C. Wainwright expects a three-year hold successful the rollout of relacorilant, with a caller expected motorboat successful the archetypal 4th of 2029.

Corcept Therapeutics Incorporated (NASDAQ:CORT) is simply a California-based institution that discovers and develops solutions for superior endocrinologic, oncologic, metabolic, and neurologic disorders. Founded successful 1998, the institution is committed to unlocking “the imaginable of cortisol modulation.”

While we admit the imaginable of CORT arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money.

Disclosure: None.